It's worth noting that the gastric emptying effect tends to attenuate over time with continued treatment
(NASDAQ: VKTX) reported completion of enrollment in its phase 3 VANQUISH-2 trial evaluating VK2735, its dual GLP-1/GIP receptor agonist candidate for obesity treatment
A telehealth intake form that does not specifically ask about MEN2 or MTC family history, or that relies on a patient correctly self-identifying those diagnoses, is a gap that in-person endocrinology care closes more reliably
STEP 5 (2-year study): Fewer than 4% of participants discontinued due to side effects, demonstrating strong long-term tolerability when doses are managed according to protocol
So, you eat fewer calories, resulting in weight loss
A major cause of CVD is atherosclerosis, a chronic inflammatory disease characterized by the pathogenic accumulation of vascular smooth muscle cells (VSMC), oxidized lipids and immune cells in the artery wall 2,3,4